State-of-the-Art Methods for Skeletal Muscle Glycogen Analysis in Athletes - The Need for Novel Non-Invasive Techniques by Greene, J et al.
  
Biosensors 2016, 6, x; doi: FOR PEER REVIEW  www.mdpi.com/journal/biosensors 
Review 1 
State-of-the-Art Methods for Skeletal Muscle 2 
Glycogen Analysis in Athletes - The Need for Novel 3 
Non-Invasive Techniques  4 
Jacob Greene1, Julien Louis2, Olga Korostynska3 and Alex Mason4* 5 
1 Department of Built Environment; Faculty of Engineering and Technology; BEST Research Institute, 6 
Liverpool John Moores University, Liverpool, England. J.Greene@2013.ljmu.ac.uk  7 
2 Faculty of Science, School of Sports and Exercice Science, Liverpool John Moores University, Liverpool, 8 
England. J.B.Louis@ljmu.ac.uk  9 
3 Department of Civil Engineering, Faculty of Engineering and Technology, Liverpool John Moores 10 
University, Liverpool, England. O.Korostynska@ljmu.ac.uk  11 
4 Department of Built Environment, Faculty of Engineering and Technology, Liverpool John Moores 12 
University, Liverpool, England. A.Mason1@ljmu.ac.uk  13 
 14 
* Correspondence: A.Mason1@ljmu.ac.uk; Tel.: +44 -151-231-4335 15 
Academic Editor: name 16 
Received: 31st October 2016; Accepted: date; Published: date 17 
Abstract: Muscle glycogen levels have a profound impact on an athlete’s sporting performance, thus 18 
measurement is vital. Carbohydrate manipulation is a fundamental component in an athlete’s 19 
lifestyle and is a critical part of elite performance, since it can provide necessary training 20 
adaptations. This paper provides a critical review of the current invasive and non-invasive methods 21 
for measuring skeletal muscle glycogen levels. These include, the gold standard muscle biopsy, 22 
histochemical analysis, magnetic resonance spectroscopy and musculoskeletal high frequency 23 
ultrasound, as well as pursuing future application of electromagnetic sensors in the pursue of 24 
portable non-invasive quantification of muscle glycogen. This paper will be of interest to researchers 25 
who wish to understand the current and most appropriate techniques in measuring skeletal muscle 26 
glycogen and to seek understanding in the need for development in equipment which can be used 27 
in, e.g., elite sporting competition and improve physiological training adaptations to carbohydrate 28 
manipulation.   29 
Keywords: muscle glycogen; carbohydrates; muscle biopsy; magnetic resonance spectroscopy; 30 
musculoskeletal ultrasound; electromagnetic sensors  31 
 32 
1. Introduction 33 
Over recent decades, technology has evolved the professional sporting environment, with the 34 
ever more acceptance that meticulous attention to detail can make the difference between winning 35 
and losing. However, the process of collecting accurate data requires adapted equipment and 36 
methods often expensive and invasive, such as muscle biopsies to estimate glycogen concentration 37 
or venepuncture to estimate blood minerals and lactate. Athletic performance can translate into many 38 
other areas where optimal human performance is not only a fundamental requirement but also a 39 
necessity. Aerospace, military, aircraft, medical and many more personnel all need to be at peak 40 
physical and mental performance to ensure optimal results. Sensor technology which can constantly 41 
monitor the biology of an individual in such extremely taxing situations will ensure that error is 42 
limited, making the vital difference in the ever advancing world.  43 
 44 
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Advances in technology have permitted endurance athletes, sports teams, and physicians to monitor 45 
player movements [1] workloads [2] and biometric indicators [3] enabling optimisation of athlete 46 
performance and also reducing the risk of injury. To date there are few technologies’ that allow the 47 
analysis of real-time physiological factors. The sensors in this research allow further data to be 48 
collected for individual physiological player monitoring. Sensors that determine physiological 49 
response to changes in competition and training allow many benefits for sports practitioners such as 50 
nutritionists, injury rehab professionals, and strength and conditioning coaches, etc. This ability 51 
undoubtedly will lead to a more individualized approach for the athletes, which is vital at the elite 52 
end of the performance spectrum.  53 
There has been some work demonstrated in literature regarding the measurement of skeletal muscle 54 
glycogen, however the existence of convenient non-invasive real-time measurement techniques 55 
remains elusive. In addition, there has never been a comprehensive review of the available 56 
technologies for such measurements. Therefore, this paper aims to critically review the current state 57 
of the art in this area, and identify promising techniques that could achieve non-invasive and real-58 
time monitoring. 59 
2. Importance of muscle glycogen 60 
Muscle glycogen provides the main source of energy during anaerobic exercise. Furthermore, total 61 
glycogen stores within the body also contribute significantly to energy metabolism in endurance-62 
type events lasting longer in duration. Therefore, endurance based events lasting up to 3 require 63 
strategic preparation of carbohydrate (CHO) based fuels (muscle and liver glycogen, blood glucose 64 
and blood muscle and liver lactate) to sustain the high demands for energy production [4-6]. 65 
Glycogen and the enzymes responsible for glycogen synthesis (glycogenesis) are contained within 66 
the cytoplasm of liver and muscle cells. Excess glucose under normal circumstances following the 67 
ingestion of carbohydrate, enters the pathways of energy metabolism where it’s either stored as 68 
glycogen, or converted to fat. Glycogenesis is the formation of glycogen from glucose. The demand 69 
for glucose and ATP (adenosine triphosphate) depends on the rate that glycogen is synthesized. If 70 
both glucose and ATP are present in substantial amounts, then the surplus of insulin stimulates 71 
glycogenesis for storage in the liver and muscle cells. Glycogen is the principal d-glucose storage 72 
polymer in humans. Most human cells have glycogen, but only liver and skeletal muscle cells are able 73 
to storage significant quantities of this molecule [7]. Glycogen is a polysaccharide, compose of 74 
hundreds of glucose molecules (monosaccharides) joined end to end, with prevalent branches.  75 
Osmotic pressure is dependent on the number, not the size, of dissolved substances.  76 
A single glycogen molecule may contain 5,000 glucose units compared to that of 5,000 individual 77 
glucose molecules. This explains why glycogen is a convenient way to store glucose inside cells 78 
without affecting cell osmotic pressure [8]. Glycogen contains a number of OH groups, which allows 79 
for the interaction with water in the cell, this means that in terms of weight, glycogen is a substantial 80 
fuel [9]. Rates of post-exercise glycogen synthesis are integral to an athlete’s regime, this allows the 81 
athlete to ensure sufficient energy stores for the following day, a fundamental component in events 82 
which take course over many days. Without consumption of CHO post-exercise, glycogen synthesis 83 
occurs at rates of 1-2 mmol/kg wet weight (w.w) of muscle/h through gluconeogenesis [10]. However, 84 
when large amounts of CHO are consumed post-exercise, glycogen synthesis improves greatly, rates 85 
of resynthesize increase to within the range of 5-10 mmol/kg w.w./h and then continue throughout 86 
the recovery stage[4]. Maximising muscle glycogen synthesis in-between important exercise sessions 87 
and events therefore is dependent on matching fuel stores closely with the demands of the intended 88 
exercise intensity and duration.                                                                                           89 
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Figure 1: A section of a glycogen molecule illustrating individual glucosyl units. It shows the two different types 91 
of glycosidic bonds used to make up glycogen.  92 
 93 
Carbohydrates are an important source of fuel and energy for intense and prolonged bouts of 94 
exercise. Glycogen is one of the main energy sources for ATP production to facilitate muscle 95 
contraction during a wide range of exercises, from brief high-intensity exercises to endurance 96 
exercises [11]. It has been reported that muscle glycogen content is associated with muscle 97 
performance and its depletion by high-intensity exercise leads to a decline in performance, also 98 
known as muscle fatigue [12]. Glycogen stores in human muscle and liver are determined and will 99 
vary dependent on the individuals activity status and how much CHO they consume [4]. Normal 100 
levels of muscle glycogen stores for a well-trained athlete can usually fuel sporting activity for up to 101 
60-90 minutes [13]. Muscle glycogen levels have a profound impact on an athlete’s sporting 102 
performance, thus measurement is vital. Although fatigue is a complex process involving many 103 
variables, there is a large amount of evidence to suggest the main cause of fatigue during endurance 104 
exercise is reduced muscle glycogen and blood glucose availability, which reduces the availability of 105 
substrate required to maintain the high CHO oxidation rates necessary to sustain high power outputs 106 
[14]. During exercise, CHO availability to the working muscle and central nervous system could 107 
become compromised due to the athlete exceeding endogenous stores of CHO when fuel cost is more 108 
than expected during either training or competition, reducing performance [15]. 109 
 110 
Figure 2: Muscle glycogen use during exercise at different intensities (adapted from Gollnick et al., 1974)  111 
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The promotion of high CHO availability for prolonged exercise is widely established [16] to 112 
ensure there is enough muscle substrate to match the demands of the intensities and volume of 113 
endurance training and competition. To do this one of the most regular requests by a nutritionist or 114 
coach to an athlete is to undergo CHO loading to super-compensate muscle and liver glycogen stores 115 
in the days before a major endurance competition. As well as ensuring a diet high in CHO, during 116 
competition the athlete will also be advised to ingest drinks, bars and gels with a high CHO content 117 
[16]. Muscle glycogen is widely recognised as the primary fuel source for sustaining contractile 118 
activity in human skeletal muscle [11] Thus, the ability of skeletal muscle to perform repeated 119 
contractions (exercise) is seriously compromised when muscle glycogen reserves reach low levels 120 
[11,17,18] demonstrating a clear association between muscle glycogen and fatigue resistance during 121 
both prolonged and high-intensity exercise. To this end, it is widely recommended that exercise 122 
should be commenced with high carbohydrate (CHO) availability in order to optimise performance 123 
and delay fatigue [19]. In another hand recent research has also demonstrated that deliberately 124 
reducing the CHO availability around training sessions (i.e. by using fasted training, sleeping low, 125 
recovering low, training twice a day) is also shown to up regulate the physiological adaptation to 126 
training [19].  Consecutively the concept of CHO periodisation has been introduced to help athletes 127 
both enhance the adaptive response to training (through low CHO availability around certain 128 
training sessions) and enhance exercise capacity in competition (through high CHO availability 129 
during all competitions) [20,21]. 130 
 131 
Figure 3: Relationship between muscle glycogen content, exercise capacity and diet (adapted from 132 
Bergstrom et al. 1967)  133 
3. Current athlete recommendations   134 
Given the high training loads of elite athletes, traditional nutritional guidelines have typically 135 
advised a high carbohydrate (CHO) diet in addition to exogenous CHO provision during exercise 136 
and within the immediate recovery period following exercise[19]. However, research gathered over 137 
the last decade has established that systematically commencing exercise with low muscle glycogen 138 
and limiting CHO intake during exercise, supplements a number of markers of mitochondrial 139 
biogenesis[16]. Current recommendations involve the periodization of carbohydrates, alternating 140 
periods of low of high CHO availability according to the training load [22]. As such, most recent 141 
guidelines for CHO intake for training and competition [19] recognise that there is a need for a flexible 142 
and individual approach to the intake of CHO, dependant on such factors as training status, type of 143 
training and the time to competition. Current guidelines are seen to promote a sliding scale of CHO 144 
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intake with the goal of matching the predicted energy expenditure of the athletes training and 145 
recovery [23]. This research therefore shows the need to be able to monitor an athlete’s glycogen 146 
stores to suit the specific needs of the athlete during the cycles of training and competition.   147 
Untrained individuals consuming a mixed diet normally have a skeletal muscle glycogen content of 148 
∼80–90 mmol kg−1, however for athletes involved in regular endurance training; this amount is higher 149 
at around 125 mmol kg−1 [24]. As 1 g of glycogen is usually stored with 2-3 g of water, a negative of 150 
glycogen loading is that the athletes body mass will likely increase by around 102% after a period of 151 
several days CHO ‘loading’ [16]. CHO loading is the process endurance athletes undertake prior to 152 
competition to super-compensate glycogen stores to reduce the effects of muscle glycogen depletion 153 
on fatigue and exercise capacity [11]. A practical example of CHO loading is reported by Bussau et al 154 
[25] who reported that elevated muscle glycogen stores may be achieved in as little as 24–36 h of rest 155 
and high CHO intake (8–12 g kg day−1), which is a strategy for athletes which are participating in 156 
weekly cycles of competition. Being able to monitor glycogen stores during real time will allow 157 
development of strategic training programs which cater for specific needs of athletes. Recent studies 158 
which used a variety of strategies to reduce CHO stores manipulating CHO availability in both 159 
endogenously and/ or exogenously during short term training interventions have reported strong 160 
up-regulation of training adaptation including increased whole body fat oxidation and increased 161 
activities of oxidative enzymes, when they were compared with exercising with normalized glycogen 162 
stores and high CHO availability [13,26,27] as well as increasing whole-body and intramuscular lipid 163 
oxidation [13,28].  164 
 165 
The practical application of training with lowered CHO availability (typically called “train low”) is 166 
still in its early states as there are known limitations and risk factors associated with training 167 
consistently with low CHO stores. Training repeatedly with low CHO stores is reported to lead to an 168 
inability to maintain the preferred training intensity [13,28] this could furthermore lead to a 169 
substandard training impulse (i.e. volume x intensity). CHO restriction during training which is of 170 
high-intensity or long in duration can also have negative effects on athlete’s health, making them 171 
more susceptible to illness and infection, this is due to the role CHO have in offsetting exercise-172 
induced immunosuppression [29]. Another factor to consider is the increase of muscle protein 173 
breakdown, especially with conditions of low muscle glycogen [30]. The advantages and limitations 174 
of altering CHO stores throughout training has widely become one of the most debated topics for 175 
athletes, coaches, nutritionists and scientists. The importance of being able to record and measure 176 
CHO stores therefore is essential to provide real time non-invasive data, providing practical methods 177 
for real world situations.  178 
4. Methods of Measuring Muscle Glycogen in Athletes 179 
4.1 The elusive gold standard  180 
Currently the typical method to measure muscle glycogen requires an invasive muscle biopsy.  181 
Involving the use of needles, muscle biopsies have been the standard method to measure muscle 182 
glycogen. This procedure is common among sport science but does have its draw backs due to its 183 
invasive nature. The percutaneous biopsy technique is known to obtain skeletal muscle tissue 184 
specimens from human subjects. Duchenne (1806-1875) is recognised for the construction of the first 185 
needle with a trocar to obtain skeletal muscle from living subjects using this biopsy method [31]. 186 
Bergström in the 1960’s developed a needle similar to that previously used by Duchenne [32,33]. The 187 
modified Bergström technique which is still being used today was developed in the 1980’s by Evans 188 
et al [34]. This technique uses the addition of suction (700 TORR) to the inner bore of the biopsy needle 189 
after the needle has been inserted into the subject's muscle. The suction is designed to pull the 190 
surrounding muscle tissue into the needle, consequently insuring the taking of a larger piece (X = 78.5 191 
mg) [34]. The advantages of this technique eliminate the need for recurring biopsies because of 192 
inadequate muscle sample size and improve the validity of subsequent analysis procedures [35], thus 193 
making it a recognised method in clinical and biomedical research environments.  194 
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Figure 4: Illustration of an invasive muscle biopsy being performed on the gastrocnemius muscle.  196 
The modified Bergström is invasive but ensures that it is causes as little damage as possible, making 197 
the procedure relatively safe.  The technique elevates the quality of the sample collected during the 198 
testing, whilst doing so under minimal time restrains for what is needed. Multiple biopsies can be 199 
taken from one subject during that specific session and the procedure can be completed quickly when 200 
the correct preparation is in place [31], this allows for pre-, mid-, and post-exercise biopsies to be 201 
taken. Another advantage of biopsies is it allows the measurement of many different outcome 202 
variables, not only the analysis of muscle glycogen stores, being useful when other parameters are 203 
investigated. Other outcome measures include for example, fibre typing, muscle damage, different 204 
fuel substrate stores, mitochondrial biogenesis and respiration, enzyme activity, shifts in metabolites 205 
and protein synthesis [31]. 206 
A current example of a muscle biopsy needle that is used in a sporting context is Monopty 12G, 207 
disposable core biopsy instrument (BARD, Brighton, UK), this needle has been used to provide field 208 
data in professional rugby players to measure muscle glycogen utilisation pre and post-game [36]. 209 
Once the biopsy has been taken it is then essential to immediately snap freeze in liquid nitrogen and 210 
stored at −80 °C for later analysis, this therefore shows the delay in time and resources that is required 211 
to gain a true muscle glycogen reading and why a non-invasive sensor could provide a practical and 212 
time saving method to the professional world of elite performance.  213 
 214 
Figure 5: Illustrates the Monopty 12G, disposable core biopsy instrument (BARD, Brighton, UK) being used on 215 
an athlete’s vastus lateralis. 216 
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Although the use of biopsies is relatively safe, practicality in a sports setting to regularly measure 217 
skeletal muscle for the analysis of CHO stores is limited due to the invasive nature of the testing. 218 
Indeed, biopsies generally have to take place within a biomedical research setting in order to limit 219 
the risk of infection. After the athlete has undergone a biopsy, it usually takes up to 5-7 days for 220 
soreness and swelling to fully dissipate. Although it is very rare, infection can accrue post procedure 221 
due to a number of factors. Tarnoplsky et al research reports taking 13,914 biopsies in both adults and 222 
children, with a total of 22 complications throughout [37]. Complications were as follows, local skin 223 
infections (8 cases), arterial bleed (2 cases), ecchymosis/hematoma (2 cases), pain persisting for more 224 
than 3 days (5 cases) and a small area local numbness distal to the biopsy (5 cases) [37].  225 
 226 
Most subjects experience local soreness and stiffness in the leg for two or three days after the biopsy 227 
similar to a deep bruise, which is a key factor in why performing a biopsy before competition can be 228 
difficult to achieve due to the distractions it can cause for the athlete. There is a very low risk of 229 
internal bleeding at the biopsy site, which can result in more prolonged pain and stiffness in the leg. 230 
On occasions, a small lump of scar tissue may form under the site of the incision, but this normally 231 
disappears within 2-3 months, or within a few weeks if massaged. A small visible scar often remains 232 
from the biopsy incision. There is the possibility of a small area of numbness (about the size of a two 233 
pence piece) around the biopsy site. This usually resolves over 5 – 6 months. There is a very low risk 234 
(estimated at less than 1/5000) of damage to small nerve branches within the muscle. This would 235 
result in partial weakness of the muscle and would likely have no impact on day-to-day activities. 236 
Nerve injuries like this usually resolve in 8 – 12 months, but there is a theoretical risk of mild leg 237 
weakness. 238 
4.2 Histochemical methods 239 
Once muscle biopsy samples have been removed, standard procedure requires the sample is 240 
immediately frozen in liquid nitrogen and stored at -80oC. Collagen, blood, and other non-muscle 241 
fibre materials are then removed from the sample from under a microscope by a trained lab 242 
technician. The sample of muscle fibre (2-3 mg) are then weighed and 500 µl of 1 mol hydrochloric 243 
acid/L are added. After heating for 3 hours at 100oC to hydrolyse the glycogen to glycosyl units and 244 
cooling down to room temperature, the solution is then neutralized by adding 267 mL tris/KOH. To 245 
conclude the procedure, 150 µl is then analysed for glucose using a calibrated specialised glycogen 246 
assay kit. After a muscle biopsy has been performed and the sample is prepared to use, glycogen 247 
content can be measured by biochemical techniques; however, such techniques are most often 248 
performed on muscle homogenates, and can therefore not discriminate between intramyocellular and 249 
extramyocellular glucose stores, and do not allow for muscle fibre typing. In order to measure only 250 
intramyocellular energy stores and to differentiate between the different fibre types, histochemical 251 
methods have been extensively used [38].  252 
 253 
Figure 6: The presence of glycogen is shown by the loss of staining after enzyme treatment when compared 254 
to the untreated segments.  255 
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Periodic Acid-Schiff (PAS) stain is based on the reaction of periodic acid with the diol functional 256 
groups in glucose and other sugars, oxidizing them to form aldehyde, which in turn reacts with the 257 
Schiff reagent to give a purple/magenta stain [38]. PAS stain is therefore not specific to glycogen; it 258 
also stains glycoproteins and proteoglycans. In order to single out glycogen form the other PAS-259 
reactive cellular components cryosections can be pre-treated with the glycogenolytic enzyme diastase 260 
[7]. The down side is that many published studies don’t use this process and therefore glycogen 261 
content can be overestimated [38].  A study by Fairchild & Fournier [39] revealed that thawing and 262 
air drying muscle cryosections consequences in glycogen degradation. However, it is common 263 
practice in laboratories, where histochemical measurements of glycogen in tissue cryosections are 264 
done by PAS staining, to still thaw and dry tissue cryosections after cutting and before fixation [38].  265 
New research which enables laboratories to optimizes skeletal muscle preservation and increased 266 
stain specificity is to use the monoclonal anti-glycogen IgM antibody [40]. For optimal preservation 267 
of glycogen stores, muscle cryosections should not be air-dried. Any cycle of freezing/thawing should 268 
be avoided due to the resulting effect in loss of glycogen particles [39]. To increase the specificity of 269 
the glycogen staining, use of a monoclonal antibody is recommended by Prats et al [38].  270 
4.3 Magnetic resonance spectroscopy  271 
Magnetic resonance spectroscopy (MRS) is a usually done alongside the more commonly used 272 
magnetic resonance imaging (MRI) scan. MRS measures the chemical content of MR-visible nuclei, 273 
which include the metabolically elements of hydrogen (1H), carbon (13C), and phosphorus (31P) [41].  274 
Whereas MRI establishes the spatial distribution of water (and Lipid) protons within the site of 275 
interest [41]. MRS is performed using the same machine as conventional MRI scanner, using a 276 
powerful magnet, radio waves, and a computer to create detailed images. Spectroscopy is a series of 277 
tests that are added to the MRI scan across specific regions of the body for chemical metabolism. 278 
There are no known health risks associated with the magnetic field or the radio waves used in either 279 
MRI or MRS and all contrast agents used are all deemed safe and are FDA-approved.  280 
 281 
Figure 7: Example of a MRI machine and illustrates how the subject is required to be fully stationary during the 282 
procedure.  283 
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During the procedure, a radiology technologist will perform the test in the MRI suite in a 284 
hospital’s radiology department or an outpatient imaging center. MRS is used to non-invasively 285 
measure tissue glycogen by either using 13C natural abundance levels, or 13C atoms incorporated into 286 
glycogen by 13C substrate received through ingestion or intravenous administration. The other 287 
method is to use the water signal with chemical exchange saturation transfer imaging (glycoCEST) 288 
[42,43]. Recent advances over the last two decades within the field of MRS technology now allows 289 
the ability to detect changes in a variety of different intramuscular fuel sources, such as muscle 290 
glycogen non-invasively [44-46].  When access to MRS is available, it can be a useful tool to measure 291 
athlete’s physical condition during valuable times in their calendar (pre-season, mid-season, end of 292 
season), this allows for the evaluation of the athlete’s performance.  293 
The need for extremely accurate methods to detect small changes in glycogen levels began when it 294 
was discovered that in diabetic subjects, responses to physiologic hyperinsulinemia caused changes 295 
in glycogen concentrations which were too small to be detected by the current biopsy techniques [47]. 296 
It was recognised that this was firstly done by obtaining the 13C nuclear magnetic resonance (NMR) 297 
spectra of human muscle glycogen in vivo from the 1.1 percent carbon nuclei that naturally occurs as 298 
this isotope [48]. Furthermore, NMR measurements of glycogen concentrations can be made more 299 
accurate by infusing 13C-enriched glucose [49]. 13C nuclear magnetic resonance (NMR) spectroscopy 300 
was validated by Taylor et al[46], the study compared the NMR to muscle biopsies and direct 301 
biochemical assay for glycogen concentrations. The results reported that in vivo, 13C NMR 302 
measurement of human muscle glycogen can be considered just as accurate as biopsy results as well 303 
as deliver a higher precision measurement than a biopsy with a direct biochemical assessment.  This 304 
technology now proven to allows for the non-invasive method to analyse muscle glycogen, it have 305 
fast time resolution making for fast results, can be repeated as many times necessary, and provides 306 
very accurate date. However, gaining access to this expensive specialised equipment is limited and 307 
MRS does not have the ability to distinguish between muscle fibre types, MRI machines are also not 308 
portable which make the use in an athletic situation not available.  309 
 310 
4.4 Musculoskeletal high frequency ultrasound  311 
 312 
Ultrasound has functioned as a valuable imaging modality in medicine for many decades, in more 313 
recent years it has gained increasing practical application and attention in the area of sports medicine. 314 
Ultrasound is currently established for evaluating the cardiovascular status among athletes, 315 
musculoskeletal pathology diagnosis and therapeutic interventions, and to visualize and monitor 316 
real-time movement of muscles and tendons [50,51]. Musculoskeletal ultrasound has established 317 
more promise as a point of care device to use within the field, rather than having to incorporate 318 
specialised laboratories and technicians.  Musculoskeletal ultrasound is not only being utilised as a 319 
diagnostic tool but has a therapeutic use in treating a vast range of different musculoskeletal 320 
conditions affecting athletes [51]. Furthermore, ultrasound velocity, now allows for the possible 321 
detection of hydration status [52]. This technique was used in a recent study accessing changes in 322 
hydration status among National Collegiate Athletic Association Wrestlers, the protocol included the 323 
wrestlers to undergo acute bouts of dehydration flowed by a 2-hour rehydration period. The results 324 
demonstrated the potential use of ultrasound technology being deployed as a means of assessing 325 
field-based hydration status of athletes [53].In comparison to the aforementioned methods, 326 
ultrasound technology prompts a practical solution in providing a non-invasive and relatively cheap 327 
alternative procedure to detect muscle glycogen. This technique determines muscle glycogen content 328 
within the muscles by detecting the variations in the grey scale image, accessing the association 329 
between water content and glycogen values [54]. Ultrasound technology is used frequently in 330 
medicine, and has promising advantages compared to the previous techniques mentioned within this 331 
review such as portability, low cost, no harmful ionizing radiation, real time, and also causes no 332 
discomfort or any long-term side effects.  333 
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(A)                                          (B) 335 
Figure 8: (A) Application of ultrasound and equipment involved, (B) Example of a grey scale image 336 
produced by an Ultrasound when placed directly upon skeletal muscle.  337 
Recently methods have been designed to try and overcome the invasive nature of biopsies.  338 
MuscleSound© have attempted to design software to enable the ability to use ultrasound to measure 339 
skeletal muscle glycogen.  MuscleSound© methodology is based upon the measurement of the water 340 
content which is associated with glycogen in the muscle. When muscle glycogen is high, the 341 
ultrasound image is hypoechoic (dark), and when used for a muscle which has low stores of glycogen 342 
and has water loss, the image is hyperechoic (brighter) [55]. The idea behind the MuscleSound© 343 
software is to then quantify the observed changes in muscle glycogen levels using image processing 344 
and analysis through segmentation of the area that is of interest and measurement of the mean signal 345 
intensities [55].  346 
Research by Nieman et al [55] assessed the use of the ultrasound method using a high resolution GE 347 
LOGIQ-e ultrasound machine (GE Healthcare, Milwaukee, WI) alongside MuscleSound© software for 348 
the ability to measure exercise-induced changes in skeletal muscle glycogen content. Well-trained 349 
cyclists endured in a 75-km cycling time trial. Muscle biopsy samples and ultrasound measurements 350 
were acquired pre- and post-exercise. Ultrasound images were pre-processed to isolate the muscle 351 
area under analysis, with the mean pixel intensity averaged from the three scans and scaled (0 to 100 352 
scale) to create the glycogen score. Pre- and post-exercise muscle biopsy samples were acquired at 353 
the vastus lateralis location using the suction-modified percutaneous needle biopsy procedure, and 354 
analyzed for glycogen content. MuscleSound® change scores attained from an average of three 355 
ultrasound scans at the vastus lateralis site correlated significantly with change in vastus lateralis 356 
muscle glycogen content [55]. The data found in this specific study showed that MuscleSound® 357 
methodology was able to accurately and non-invasively estimating exercise-induced decreases in 358 
vastus lateralis skeletal muscle glycogen content. 359 
However, further research is still needed to ensure this is a viable method to measure muscle 360 
glycogen in athletes under a number of variations. Recent examination of this technique by Bone et 361 
al [54] reported that ultrasound technology failed to measure indirect estimates of muscle glycogen 362 
concentrations. The study aimed to validate ultrasound technology for the measurement of muscle 363 
glycogen concentrations in well-trained individuals under different conditions which were 364 
previously tested by Neiman et al. This conditions included normal glycogen levels, depleted 365 
glycogen levels and loaded levels of glycogen. In addition, creatine loading was consumed by some 366 
subjects to provide a possible confounding effect on muscle water content [54].  Again 367 
MuscleSound® software was used to interpret the ultrasound images and was compared to that of 368 
the suction-modified percutaneous needle biopsy procedure. The results from this study we unable 369 
to validate the use of ultrasound technology to estimate muscle glycogen or increases/decreases in 370 
these stores across a range of scenarios including exercise-depletion, normalized stores, carbohydrate 371 
loading and concomitant creatine loading [54]. 372 
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To critically compare the above discussed methods for glycogen detection, one may refer to table 1 374 
below, which provides a comparison of the techniques in terms of portability, accuracy, time needed 375 
to perform measurements, size and cost.   376 
 Table 1: Assessment of current techniques to detect muscle glycogen in athletes  377 
Although the use of non-invasively measuring muscle glycogen content non-invasively with a 378 
portable deceive is appealing, more research and development is needed to ensure valid and reliable 379 
results in the world of elite sport under varying environmental conditions.  However, this is hopeful 380 
for the future and if corrections are made, this technology would have extensive application in 381 
applied sports nutrition. 382 
4.5 Advances in sensor technology to detect physiological markers 383 
Although currently there aren’t any sensors with the specialised capability of detecting muscle 384 
glycogen non-invasively, it is key to highlight similar efforts at the forefront of current technology 385 
which have enabled previously invasive methods of personal health monitoring and optimal 386 
performance tracking to become real-time and non-invasive. Furthermore, technology is constantly 387 
improving, it is estimated in the next few years such equipment will be available on the market to 388 
measure such parameters.  Electromagnetic (EM) waves are waves of energy that travel through a 389 
vacuum at the speed of light, which is approximately c=3x108 m/s [56,57]. Microwave detection in 390 
physiology is an emerging new field offering a vast range of applications. Microwave sensors provide 391 
a real-time non-invasive method of analysis, which is cost-effective, robust and has many practical 392 
applications from a sport and athletic stand point but yet there has been no successful attempt within 393 
this industry. This revolutionary system eliminates the need of blood samples, muscle biopsies, and 394 
other invasive methods for the selected parameters by being placed over the blood vessels on the 395 
skin. Microwave sensor technology has the hope of being able to detect an array of different 396 
parameters, these may include (but not limited to): muscle glycogen, blood lactate, blood 397 
oxygenation, water content and muscle proteins consecutive to exercise-induced muscle damage.  398 
The above parameters are monitored by sending electromagnetic waves through the skin and sensing 399 
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reflection, this technique uses extremely low levels of radiation (three to four orders of magnitude 400 
lower than that of mobile-phones) avoiding any exposure to harmful radiation. 401 
 402 
(A)                                            (B) 403 
Figure 9: (A) Experimental setup, showing participant on ergometer with sensors attached and appropriate 404 
data acquisition hardware: (B) illustrates placement of sensors both arm and leg during a blood lactate exercise 405 
protocol.  406 
Previous research using this technology has demonstrated the ability to detect a variety of 407 
different substances such as, glucose at physiological levels as well as lactate in water and types of 408 
oils [58-60].The study by Goh et al [61] used this microwave sensing platform to successfully detect 409 
lactate in cerebrospinal fluid. This shows application of this technology could provide masses of 410 
benefits to a variety of different practitioners within the world of sports and performance who want 411 
to be able to quantify previously difficult performance markers both in the labs and in the field. The 412 
sensor uses electromagnetic waves of 300 MHz to 300 GHz, the sensor is based on conductivity 413 
(ability of a material to conduct an electric current) and permittivity (which depends on the dielectric 414 
constant of the material) [62]. The use of a non-invasive sensor allows for durability, simple design, 415 
portability, and ability for real time analysis [63-65]. Although this technique is a promising concept, 416 
further research and development is needed before the sensors will impact the world of sports and 417 
exercise science.  418 
In recent years, there has been successful attempts in the development of sensors that process 419 
the ability to detect glucose levels non-invasively for patients involved in diabetes management. The 420 
prerequisite for non-invasive detection was due to the need in avoiding the complex, costly and 421 
painful nature of conventional (invasive) glucose monitoring. Glucose monitoring is of special 422 
importance because of its involvement in the human metabolic process, giving promise to the future 423 
of non-invasive glycogen sensors. Jiang et al. [66] developed a sensitive glucose biosensor designed 424 
by the immobilization of Os-complex mediator and glucose oxidase on the electrode surface. The 425 
biosensor successfully determined the glucose extracted from the skin by reverse iontophoresis (the 426 
transport of glucose outward from the skin) and demonstrated a relative amperometric reaction to 427 
accumulative subcutaneous glucose levels [67]. This is one of many examples of successful non-428 
invasive glucose monitoring which have come about only in the last decade which alongside reverse 429 
iontophoresis[68] include, bioimpedeance spectroscopy[69], ultrasound / electromagnetic and heat 430 
capacity[70], Laser microporation[69] and the Prelude® SkinPrep[71] system as well as many more 431 
systems which are still lacking well-documented clinical trials but give assurance in the future of an 432 
affordable non-invasive glycose monitoring[72]. Although non-invasive detection of glucose is a 433 
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credit to the advancing personal health care monitoring technology, there is still a lot of research 434 
needed to develop similar devices for glycogen. Glycose is a much simpler molecule than glycogen, 435 
unlike glucose, glycogen is insoluble in water and cannot pass in and out of cells until glycogenolysis 436 
occurs breaking it down into smaller, more soluble units. Despite this, the use of the above techniques 437 
show promise and with the essential development could provide a method of glycogen detection.  438 
5. Conclusions and Future Research Directions  439 
With the array and emergence of new advances in medical and sporting technology over recent years, 440 
biopsies with the addition of histochemical assay still remain the preferred method of measuring 441 
muscle glycogen regardless of its non-invasive nature. This will remain so until an alternative method 442 
is available which reaches a high standard of results and allows for portable, real-time and non-443 
invasive assessments. MRS is leading the way with the non-invasive measurements of glycogen, 444 
when MRS and muscle biopsy samples are used in conjunction, the biopsy can be used to measure 445 
other metabolic variables such as enzymatic activities leaving MRS to detect glycogen levels, this is a 446 
rewarding combination for a coach and sports scientists who can then develop a strategy to optimize 447 
athletic performance.  However, MRS is not a feasible option in the world of elite sport due to the 448 
costs, lack of specialist equipment available, and not being transportable. MRS isn’t readily available 449 
because it requires the use of an MRI machine, usually within a hospital setting. To date research into 450 
the measurement of muscle glycogen using MRS and focuses mainly on the clinical side rather than 451 
athletic performance. Although data from musculoskeletal high frequency ultrasound initially 452 
showed promising results, further research has shown the floors and further development needs to 453 
be completed before this technique can be applied to the ever changing circumstances of a 454 
professional athlete’s regime. The concept of electromagnetic sensors being able to measure muscle 455 
glycogen non-invasively is a serious possibility in the near future, research and testing needs to be in 456 
conjunction with muscle biopsies to ensure accurate results and ensure a number of glycogen store 457 
manipulation strategies are in place to ensure measurements are accurate under a variety of testing 458 
condition.  459 
The need for invasive measures due to extensive use of the painful procedure involving lancet devices 460 
to prick the fingertip of diabetics taking the blood sample to frequently monitor blood glucose 461 
brought on the need to create a solution to create non-invasive devices, which over the last decade 462 
has produced successful results. Similarly, the need for non-invasive methods are present in the 463 
world of elite human performance and to provide accurate nutritional guidelines to access glycogen 464 
stores real time and avoiding biopsy’s.  465 
With recent studies researching the effects of different levels of CHO levels from ‘real life’ 466 
perspectives from the world of sport, the need for real time non-invasive measuring equipment 467 
would be ever more valuable. This would help solve many of the issues faced by scientists and 468 
coaches using invasive equipment out of the laboratory. The research that would follow would allow 469 
measurement of the athlete’s ability to repeat glycogen super compensation protocols, this ability has 470 
profound interest in elite competitors such as professional cyclists and team sport athletes who 471 
commonly perform multiple sessions of training and competition each week. 472 
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